IDNA vs. WDNA
IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) and WDNA (WisdomTree BioRevolution Fund) are both Health & Biotech Equities funds - IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index while WDNA tracks the WisdomTree BioRevolution Index. Both are passively managed. Over the past 3 years, IDNA returned 6.48%/yr vs 2.03%/yr for WDNA. Their correlation of 0.90 suggests significant overlap in exposure. IDNA charges 0.47%/yr vs 0.45%/yr for WDNA.
Performance
IDNA vs. WDNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IDNA achieves a 9.51% return, which is significantly higher than WDNA's 4.55% return.
IDNA
- 1D
- -2.18%
- 1M
- -2.18%
- YTD
- 9.51%
- 6M
- 10.53%
- 1Y
- 41.74%
- 3Y*
- 6.48%
- 5Y*
- -8.26%
- 10Y*
- —
WDNA
- 1D
- -2.61%
- 1M
- -1.27%
- YTD
- 4.55%
- 6M
- 9.65%
- 1Y
- 45.95%
- 3Y*
- 2.03%
- 5Y*
- —
- 10Y*
- —
IDNA vs. WDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 9.51% | 17.26% | -0.72% | -7.63% | -42.28% | -4.42% |
WDNA WisdomTree BioRevolution Fund | 4.55% | 22.68% | -14.18% | -2.07% | -26.29% | -5.27% |
Correlation
The correlation between IDNA and WDNA is 0.86, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.86 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.89 |
Correlation (All Time) Calculated using the full available price history since Jun 4, 2021 | 0.90 |
The correlation between IDNA and WDNA has been stable across timeframes, ranging from 0.86 to 0.90 - a consistent structural relationship.
IDNA vs. WDNA - Sectors Allocation Comparison
Sectors
IDNA
WDNA
Healthcare
Industrials
-
Basic Materials
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
Energy
-
Financial Services
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
IDNA
WDNA
Industrials
IDNA
WDNA
-
Basic Materials
IDNA
-
WDNA
Communication Services
IDNA
-
WDNA
-
Consumer Cyclical
IDNA
-
WDNA
-
Consumer Defensive
IDNA
-
WDNA
Energy
IDNA
-
WDNA
Financial Services
IDNA
-
WDNA
-
Real Estate
IDNA
-
WDNA
-
Technology
IDNA
-
WDNA
-
Utilities
IDNA
-
WDNA
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IDNA vs. WDNA — Risk / Return Rank
IDNA
WDNA
IDNA vs. WDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and WisdomTree BioRevolution Fund (WDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| IDNA | WDNA | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 1.71 | 1.81 | -0.10 |
Sortino ratioReturn per unit of downside risk | 2.48 | 2.65 | -0.17 |
Omega ratioGain probability vs. loss probability | 1.28 | 1.30 | -0.02 |
Calmar ratioReturn relative to maximum drawdown | 4.09 | 4.21 | -0.12 |
Martin ratioReturn relative to average drawdown | 11.79 | 9.61 | +2.18 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| IDNA | WDNA | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.71 | 1.81 | -0.10 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.29 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.10 | -0.22 | +0.32 |
Drawdowns
IDNA vs. WDNA - Drawdown Comparison
The maximum IDNA drawdown since its inception was -68.26%, which is greater than WDNA's maximum drawdown of -58.87%. Use the drawdown chart below to compare losses from any high point for IDNA and WDNA.
Loading charts...
Drawdown Indicators
| IDNA | WDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.26% | -58.87% | -9.39% |
Max Drawdown (1Y)Largest decline over 1 year | -10.66% | -11.70% | +1.04% |
Max Drawdown (3Y)Largest decline over 3 years | -29.73% | -38.25% | +8.52% |
Max Drawdown (5Y)Largest decline over 5 years | -68.26% | -58.87% | -9.39% |
Current DrawdownCurrent decline from peak | -46.01% | -32.70% | -13.31% |
Average DrawdownAverage peak-to-trough decline | -36.24% | -35.65% | -0.59% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.70% | 5.13% | -1.43% |
Volatility
IDNA vs. WDNA - Volatility Comparison
iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) has a higher volatility of 7.24% compared to WisdomTree BioRevolution Fund (WDNA) at 6.67%. This indicates that IDNA's price experiences larger fluctuations and is considered to be riskier than WDNA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IDNA | WDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.24% | 6.67% | +0.57% |
Volatility (6M)Calculated over the trailing 6-month period | 18.21% | 16.50% | +1.71% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.51% | 25.60% | -1.09% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.42% | 25.05% | +3.37% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.53% | 25.05% | +4.48% |
IDNA vs. WDNA - Expense Ratio Comparison
IDNA has a 0.47% expense ratio, which is higher than WDNA's 0.45% expense ratio.
Dividends
IDNA vs. WDNA - Dividend Comparison
IDNA's dividend yield for the trailing twelve months is around 1.08%, less than WDNA's 4.37% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 1.08% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
WDNA WisdomTree BioRevolution Fund | 4.37% | 4.57% | 0.75% | 0.80% | 0.38% | 0.10% | 0.00% | 0.00% |
Frequently Asked Questions
IDNA and WDNA have a correlation of 0.86, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IDNA has higher volatility (7.24%) compared to WDNA (6.67%). In terms of maximum drawdown, IDNA dropped -68.26% vs WDNA's -58.87%.
On 3-year performance, IDNA leads with 6.48% vs 2.03% for WDNA. On fees, WDNA is cheaper at 0.45% per year. On volatility, WDNA has been the lower-risk option at 6.67%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 3-year period, IDNA has performed better with a 6.48% return vs 2.03%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
WDNA is cheaper with a 0.45% expense ratio, compared with 0.47% for IDNA.
WDNA has the higher dividend yield at 4.37%, compared with 1.08% for IDNA.
IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index, while WDNA tracks WisdomTree BioRevolution Index. They also come from different issuers: iShares and WisdomTree. Their fees differ too: 0.47% for IDNA and 0.45% for WDNA.
WDNA currently has the higher Sharpe Ratio (1.81 vs 1.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IDNA and WDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer